Pure Global AI
NCT06118671Not yet recruiting

The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community

Application and Effectiveness Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients of Community
Chongqing Medical UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Diabetes
Drug/Device/Intervention
personalized lifestyle intervention by AI
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Chongqing Medical University
Location
Chongqing, China
Timeline & enrollment
Phase
N/A
Start date
Nov 07, 2023
End date
Nov 07, 2024
Enrollment
460 participants
Primary outcome

Change of HbA1c

Summary

The goal of this clinical trial is to learn about the application and effectiveness
 evaluation of artificial intelligence (AI) in lifestyle management of diabetic patients in
 community.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06118671
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06118671 through Pure Global AI's free database. This phase not specified trial is sponsored by Chongqing Medical University and is currently Not yet recruiting. The study focuses on Diabetes. Target enrollment is 460 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.